![Point-of-Care Diagnostic for Trichomonas Vaginalis Based on MedMira’s RVF Technology(R)](https://dailytalks.org/wp-content/uploads/2023/02/33435-point-of-care-diagnostic-for-trichomonas-vaginalis-based-on-medmiras-rvf-technologyr.png)
HALIFAX, NS / ACCESSWIRE / January 3, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the publication of Point-of-Care Diagnostic for Trichomonas vaginalis, the Most Prevalent, Non-Viral Sexually Transmitted Infection – (available: https://www.mdpi.com/2076-0817/12/1/77), in the special edition of Pathogens by MDPI, a Swiss based medical journal…
Read More